Toripalimab Combined With Definitive CCRT for LACC Patients
Conditions: Cervical Cancer; Chemoradiotherapy; Immunotherapy Interventions: Drug: Toripalimab; Radiation: CCRT Sponsors: Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Clinical Study on the Evaluation of the Efficacy of Cervical Cancer
Conditions: Uterine Cervical Neoplasms Interventions: Other: Observational study Sponsors: First Affiliated Hospital Xi ' an Jiaotong University; Gansu Maternal and Child Health Hospital; Hanzhong Central Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study).
Conditions: Uterine Cervical Cancer Interventions: Other: Urine sample, 1st stream; Other: Cervico-vaginal swab Sponsors: Centre Hospitalier Universitaire de Saint Etienne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
Conditions: Oropharynx Cancer, Stage I Interventions: Biological: Atezolizumab; Procedure: Transoral Surgery with cervical lymphadenctomy (neck dissection); Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging Sponsors: Emory University; National Cancer Institute (NCI); Genentech, Inc. Suspended (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
HPV DNA Self-sampling in a General Practitioner's Office.
Conditions: Cervical Cancer; HPV Infection; Precancerous Lesion Interventions: Diagnostic Test: HPV DNA self-test Sponsors: Patient Organization Veronica Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen
Conditions: Ovarian Cancer; Cervical Cancer Interventions: Drug: Efbemalenograstim Alfa Sponsors: Shandong University; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
The Effect of Cervical Cancer Awareness Education Based on Mobile Application
Conditions: Cervix Cancer; Cancer Awareness; Mobile Application; HPV; Nurse ' s Role Interventions: Behavioral: Mobile application Sponsors: Kutahya Health Sciences University; Akdeniz University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
A Study of Concurrent Chemoradiotherapy Followed by Cadonilimab （AK104） for Newly Diagnosed Local Advanced Cervical Cancer
Conditions: Cervical Cancer Interventions: Drug: AK104 Sponsors: West China Second University Hospital; Af filiated Hospital of North Sichuan Medical College; The Affiliated Hospital Of Southwest Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
Conditions: Cervical Intraepithelial Neoplasia; Cervical Cancer; Persistent Infection Interventions: Biological: Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli); Other: No intervention; Biological: Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) Sponsors: Xiamen University; Xiamen Innovax Biotech Co., Ltd; Center for Disease Control and Prevention, Sheyang County, Yancheng City, Jiangsu Province, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer
Conditions: Adult Interventions: Biological: GT101 injection; Drug: Gemcitabine injection Sponsors: Grit Biotechnology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
A Study of MGC026 in Participants With Advanced Solid Tumors
Conditions: Advanced Solid Tumor; Advanced Cancer; Metastatic Cancer; Squamous Cell Carcinoma of Head and Neck; Non Small Cell Lung Cancer; Small-cell Lung Cancer; Bladder Cancer; Sarcoma; Endometrial Cancer; Melanoma; Castration Resistant Prostatic Cancer; Cervical Cancer; Colorectal Cancer; Gastric Cancer; Gastro-esophageal Cancer; Pancreas Cancer; Clear Cell Renal Cell Carcinoma; Hepatocellular Carcinoma; Platinum-resistant Ovarian Cancer Interventions: Biological: MGC026 Dose Escalation; Biological: MGC026 Dose for Expansion Sponsors: MacroGenics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
Conditions: Metastatic Solid Tumor; Recurrent Solid Tumor; Advanced Solid Tumor; Urinary Bladder Neoplasm; Triple Negative Breast Cancer; Non-small Cell Lung Cancer; Esophageal Cancer; Pancreatic Cancer; Ovarian Cancer; Cervical Cancer; Head and Neck Squamous Cell Carcinoma; Prostate Cancer; Renal Pelvis Cancer; Bladder Cancer Interventions: Drug: LY4101174 Sponsors: Eli Lilly and Company; Loxo Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Dostarlimab and Cobolimab in Advanced Cervical Cancer
Conditions: Cervical Cancer; Advanced Cervical Carcinoma; Metastatic Cervical Cancer; Metastatic Cervical Carcinoma; Recurrent Cervical Carcinoma Interventions: Drug: Dostarlimab; Drug: Cobolimab Sponsors: Meghan Shea; GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Conditions: Biliary Tract Cancer; Breast Cancer; Cervical Cancer; Colon Cancer; Endometrial Cancer; Esophageal Cancer; Gastric Cancer; GastroEsophageal Cancer; Head and Neck Cancer; Hepatocellular Cancer; Non-small Cell Lung Cancer; Pancreatic Cancer; Prostate Cancer; Rectal Cancer; Renal Cancer; Thyroid Cancer Interventions: Drug: MDX2001 Sponsors: ModeX Therapeutics, An OPKO Health Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China
Conditions: Cervical Cancer; Endometrial Cancer; Ovarian Cancer; HER2 Expression Interventions: Other: no intervention Sponsors: Chongqing University Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
